These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Anti-cytokine therapies in chronic heart failure: is this concept still alive? Parissis JT; Kourea K; Kremastinos D Hellenic J Cardiol; 2005; 46(2):101-7. PubMed ID: 15847129 [No Abstract] [Full Text] [Related]
24. Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes. Barbour MM; Zuwallack A Med Health R I; 2001 Feb; 84(2):55-8. PubMed ID: 11272661 [TBL] [Abstract][Full Text] [Related]
27. [Administration of beta blockers for chronic heart failure]. Walma EP Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2325-6. PubMed ID: 11143301 [No Abstract] [Full Text] [Related]
28. Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study. de Peuter OR; Lip GY; Souverein PC; Klungel OH; de Boer A; Büller HR; Kamphuisen PW Eur J Heart Fail; 2011 May; 13(5):489-95. PubMed ID: 21193438 [TBL] [Abstract][Full Text] [Related]
29. [New concept in chronic heart failure. Blocking the function of tumor necrosis factor]. MMW Fortschr Med; 2000 Mar; 142(13):51. PubMed ID: 10783628 [No Abstract] [Full Text] [Related]
30. Treatment guidelines for heart failure stress multidrug approach. Morey SS Am Fam Physician; 1999 Jun; 59(11):3265-6. PubMed ID: 10392599 [No Abstract] [Full Text] [Related]
31. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162 [TBL] [Abstract][Full Text] [Related]
32. [Pharma-clinics. How I treat...symptomatic heart failure]. Kulbertus H Rev Med Liege; 1999 Jul; 54(7):625-8. PubMed ID: 10495687 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of chronic cardiac failure in 1997: obvious facts and uncertainties]. Komajda M Arch Mal Coeur Vaiss; 1997 Sep; 90(9):1205-7. PubMed ID: 9488765 [No Abstract] [Full Text] [Related]
34. TNF-alpha and heart failure. The difference between proof of principle and hypothesis testing. Francis GS Circulation; 1999 Jun; 99(25):3213-4. PubMed ID: 10385490 [No Abstract] [Full Text] [Related]
35. Brain natriuretic peptide-guided management of chronic heart failure: first do no harm. Richards AM Eur J Heart Fail; 2013 Aug; 15(8):832-4. PubMed ID: 23821462 [No Abstract] [Full Text] [Related]
36. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial. Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456 [No Abstract] [Full Text] [Related]
37. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%. Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040 [TBL] [Abstract][Full Text] [Related]
38. New therapies for heart failure. Riggs JM RN; 2004 Mar; 67(3):28-32; quiz 33. PubMed ID: 15065491 [No Abstract] [Full Text] [Related]